|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-1-3
|
|
pubmed:abstractText |
We investigated the expression of interleukin-13 receptor alpha2 (IL-13R alpha 2), EphA2, and Fos-related antigen 1 (Fra-1) in astrocytomas and normal brain. We sought to document whether the expression of the three factors changed with progression to higher grade malignancy and whether two or three targets in combination might be sufficient to target all patients with high-grade astrocytomas.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ADP Ribose Transferases,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Toxins,
http://linkedlifedata.com/resource/pubmed/chemical/Exotoxins,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-13 Receptor alpha2...,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-fos,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, EphA2,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Virulence Factors,
http://linkedlifedata.com/resource/pubmed/chemical/fos-related antigen 1,
http://linkedlifedata.com/resource/pubmed/chemical/toxA protein, Pseudomonas aeruginosa
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
199-208
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:18172271-ADP Ribose Transferases,
pubmed-meshheading:18172271-Animals,
pubmed-meshheading:18172271-Antineoplastic Agents,
pubmed-meshheading:18172271-Astrocytoma,
pubmed-meshheading:18172271-Bacterial Toxins,
pubmed-meshheading:18172271-Blotting, Western,
pubmed-meshheading:18172271-Brain Neoplasms,
pubmed-meshheading:18172271-Cells, Cultured,
pubmed-meshheading:18172271-Exotoxins,
pubmed-meshheading:18172271-Humans,
pubmed-meshheading:18172271-Immunohistochemistry,
pubmed-meshheading:18172271-Interleukin-13 Receptor alpha2 Subunit,
pubmed-meshheading:18172271-Mice,
pubmed-meshheading:18172271-Proto-Oncogene Proteins c-fos,
pubmed-meshheading:18172271-Receptor, EphA2,
pubmed-meshheading:18172271-Tissue Array Analysis,
pubmed-meshheading:18172271-Tumor Markers, Biological,
pubmed-meshheading:18172271-Virulence Factors
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy.
|
|
pubmed:affiliation |
Brain Tumor Center of Excellence, Comprehensive Cancer Center, Department of Neurosurgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
